Transmitted by Gary Christian – President, Drug Free Australia – September 18, 2025

Attached is the Drug Free Australia submission to the TGA Consultation re medicinal cannabis which is not only in  Australian National interest but also this is of concern  worldwide. DFA hopes to bring the present appropriateness of access via the Special Access Scheme (SAS) and Authorised Prescriber (AP) under control into the safety and regulatory oversight of unapproved medicinal cannabis products to protect Australia’s  future generations from harm.

From DFA’s submission’s Executive Summary:

This document addresses three of the TGA consultation questions:

• Contraindications for medical cannabis – see Appendix A
• Claims for medical cannabis not supported by rigorous science – See Appendix B
• Lack of quality assurance in the production of medicinal cannabis – See Appendix C

DFA recommendations are found on page 8.

To access the full document:

1. Click on the ‘Source’ link below.
2. An image  – the front page of the full document will appear.
3. Click on the image to open the full document.

Source:  TGA Medicinal Cannabis submission